These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32376111)

  • 1. Replication of live attenuated influenza vaccine viruses in human nasal epithelial cells is associated with H1N1 vaccine effectiveness.
    Hawksworth A; Lockhart R; Crowe J; Maeso R; Ritter L; Dibben O; Bright H
    Vaccine; 2020 May; 38(26):4209-4218. PubMed ID: 32376111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemagglutinin stability was not the primary cause of the reduced effectiveness of live attenuated influenza vaccine against A/H1N1pdm09 viruses in the 2013-2014 and 2015-2016 seasons.
    Parker L; Ritter L; Wu W; Maeso R; Bright H; Dibben O
    Vaccine; 2019 Jul; 37(32):4543-4550. PubMed ID: 31279567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of defective viral genes in H1N1 live attenuated influenza vaccine strains is not associated with reduced human cell fitness or vaccine effectiveness.
    Ayaz S; Dibben O; Chapman D
    Vaccine; 2021 Nov; 39(46):6735-6745. PubMed ID: 34663504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HA and M2 sequences alter the replication of 2013-16 H1 live attenuated influenza vaccine infection in human nasal epithelial cell cultures.
    Canaday LM; Resnick JD; Liu H; Powell H; McCoy AM; Nguyen D; Pekosz A
    Vaccine; 2022 Jul; 40(32):4544-4553. PubMed ID: 35718589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States.
    Caspard H; Coelingh KL; Mallory RM; Ambrose CS
    Vaccine; 2016 Sep; 34(42):5066-5072. PubMed ID: 27613072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemagglutinin substitutions N125D, D127E, D222G and R223Q improve replicative fitness and vaccine effectiveness of an A/H1N1pdm09 live attenuated influenza vaccine virus by enhancing α-2,6 receptor binding.
    Dempsey R; Tamburrino G; Schewe KE; Crowe J; Nuccitelli A; Dibben O
    PLoS Pathog; 2022 May; 18(5):e1010585. PubMed ID: 35622874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study to evaluate the immunogenicity and shedding of live attenuated influenza vaccine strains in children 24-<48 months of age.
    Mallory RM; Nyborg A; Kalyani RN; Yuan Y; Block SL; Dubovsky F
    Vaccine; 2020 Jan; 38(5):1001-1008. PubMed ID: 31796225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the root cause of reduced H1N1 live attenuated influenza vaccine effectiveness: low viral fitness leads to inter-strain competition.
    Dibben O; Crowe J; Cooper S; Hill L; Schewe KE; Bright H
    NPJ Vaccines; 2021 Mar; 6(1):35. PubMed ID: 33712628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
    Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
    Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain development of A/H1N1pdm09 candidate vaccine viruses for the 2021-22 northern hemisphere influenza season.
    Dempsey R; Ritter L; Parker L
    J Gen Virol; 2022 Nov; 103(11):. PubMed ID: 36409607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.
    Gauger PC; Loving CL; Khurana S; Lorusso A; Perez DR; Kehrli ME; Roth JA; Golding H; Vincent AL
    Virology; 2014 Dec; 471-473():93-104. PubMed ID: 25461535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.
    Belongia EA; Simpson MD; King JP; Sundaram ME; Kelley NS; Osterholm MT; McLean HQ
    Lancet Infect Dis; 2016 Aug; 16(8):942-51. PubMed ID: 27061888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
    Yeolekar LR; Ganguly M; Tyagi P; Ingle NB; Stittelaar KJ; Waal L; Scorza FB; Mahmood K; Dhere RM
    Vaccine; 2018 Nov; 36(46):6944-6952. PubMed ID: 30322745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated seasonal and pandemic influenza vaccine in school-age children: a randomized controlled trial.
    Klick B; Durrani S; Chan KH; Ip DK; Chou ES; Kwok HK; Ng S; Chiu SS; Peiris JS; Leung GM; Cowling BJ
    Vaccine; 2013 Apr; 31(15):1937-43. PubMed ID: 23434387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures.
    Fischer WA; Chason KD; Brighton M; Jaspers I
    Vaccine; 2014 Mar; 32(15):1761-7. PubMed ID: 24486351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells.
    Fischer WA; King LS; Lane AP; Pekosz A
    Vaccine; 2015 Aug; 33(36):4495-504. PubMed ID: 26196325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells.
    Hussain AI; Cordeiro M; Sevilla E; Liu J
    Vaccine; 2010 May; 28(22):3848-55. PubMed ID: 20307595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets.
    Broadbent AJ; Santos CP; Anafu A; Wimmer E; Mueller S; Subbarao K
    Vaccine; 2016 Jan; 34(4):563-570. PubMed ID: 26655630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological characterization of monoclonal antibodies used in rapid influenza diagnostic test for detection of the 2009 pandemic influenza A(H1N1)pdm09 infection.
    Yi H; Lee MS; Lee JY; Lee HK; Kang C
    J Microbiol; 2015 Feb; 53(2):166-75. PubMed ID: 25626373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.